Ryman Inclined to Enter Australian Market

Ryman-HealthcareRyman Healthcare is planning to construct a $100 million retirement village somewhere in Melbourne and Victoria. It declared that its first village will be built in Australia.

Though, eastern seaboard was also an option with the Company, but Victoria exhibited best opportunities.

Abano Healthcare Profit Meets its Estimates

Abano-HealthcareAccording to a recent report, Abano Healthcare has declared its profit for the year, which ended in May, to be $4.4 million.

However, the profit of the specialist medical Company has witnessed a reduction of 50% as compared to the previous year.

The reason behind it is the alterations in the ACC and the sale of its Bay Audiology venture in New Zealand in last November.

Two Pathology Companies Fined for Anti-Competitive Agreement

Two Pathology Companies Fined for Anti-Competitive AgreementA sum of $100,000 will be taken as a fine from two pathology Companies, i. e., New Zealand Diagnostic Group and Pathology Associates Limited, who confessed that they entered into an anti-competitive agreement on community testing services in the Waikato.

Mesenthes’ Product Wins Business Competition

Gerry-BrownleeMinister for Economic Development, Gerry Brownlee, declared today that Mesynthes' product Endoform Infection Control, has won the Focus on Health business competition, which was the inaugural event of New Zealand Trade and Enterprise.

The Company is situated in Lower Hutt and manufactures tissue substitute for instant use for wound care and soft tissue reconstruction.

Manitoba Nurses Accept New Agreement

Manitoba Nurses Accept New AgreementThe nurses in Manitoba have agreed to accept a new agreement with the Government and it will be applicable till March 31, 2013. The new contract received the support of 89% members of the Manitoba Nurses Union. This was decided after a voting was help across the province in Manitoba, on Wednesday.

Johnson & Johnson recalls more medicines

Johnson & Johnson recalls more medicinesJohnson & Johnson (J&J) has recalled more drugs after they were said to have been showing major side-effects. Four additional lots of Benadryl, the medicine for allergy and Tylenol gels, for giving extra strength, have been taken back from the market.